Capital Rx's Philip Vecchiolli explains how new technology provides health plans with greater transparency and an improved member experience.
14 suggestions for employers and other plan sponsors to optimize pharmacy benefits spend from Capital Rx's leadership team.
Capital Rx's Matthew Gibbs, PharmD, suggests using a more stable drug price index (NADAC) to improve access to medication in the US.
Rebates from pharmaceutical manufacturers are not the only source of revenue PBMs receive from pharma...
The Consolidated Appropriations Act includes several new fiduciary responsibilities that plan sponsors should keep in mind.
Highlights from Health Benefits Nation '22 and the Solving the Drug Spend Crisis: What Employers Can (Should) Do panel discussion...
Drug pricing indexes, mail order, and specialty home delivery explained: Our NADAC-based Clearinghouse Model®.
A Q&A with Sara Izadi, PharmD, SVP, Pharmacy at Capital Rx to shed some light on what PGx is, why it’s important, how it can help patients, and more.